Toggle Main Menu Toggle Search

Open Access padlockePrints

Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial

Lookup NU author(s): Professor Gill Rowlands, Vincent Deary

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Background People with multiple persistent physical symptoms have impaired quality of life and poor experiences of healthcare. They are commonly told their symptoms cannot be explained. We tested the effectiveness of a structured consultation intervention which aimed to validate the individual, explain symptoms using current science, and promote self-management. Methods Pragmatic multicentre individually randomised parallel group clinical trial comparing a community Symptoms Clinic plus usual care against usual care alone. Participants were recruited from GP practices in four regions of England between 06/12/2018 and 21/12/2021. Eligibility comprised coded symptom syndrome(s), specialist referrals in the preceding 3 years and multiple physical symptoms (PHQ-15 between 10 and 20). Individuals with diseases likely to cause multiple symptoms were ineligible. The symptoms clinic is an extended medical consultation intervention with four key components: recognition, explanation, action and learning. It involves 4 sessions (total 2 hours) over 8 weeks and is delivered by GPs with Extended Role. The primary outcome was physical symptoms (PHQ-15) at 52 weeks, analysed by intention to treat. Trial registration: ISRCTN 57050216 Findings 354 individuals were randomised (176 control, 178 intervention). 156 participants (87.6%) in the intervention arm completed at least 2 clinic sessions. Primary outcome was completed by 276 (78.0%) participants. Mean PHQ-15 fell from 14.9 (3.0) at baseline to 14.1 (3.7) at 52 weeks in the control group and from 15.0 (2.9) to 12.2 (4.5) in the intervention group. The between group difference, adjusted for age, gender, baseline PHQ-15, and clinician effect was -1.82 (95%CI -2.67 to -0.97, p <0.0001). There were 39 adverse events in the control group and 36 in the intervention group, with no instances of delayed diagnosis of serious disease due to focusing on symptom management. Conclusion: A Symptoms Clinic focused on explaining persistent symptoms to support self-management leads to sustained improvement in physical symptoms.


Publication metadata

Author(s): Burton C, Mooney C, Sutton L, White D, Dawson J, Neilson AR, Rowlands G, Thomas S, Horspool M, Fryer K, Greco M, Sanders T, Thomas RE, Cooper C, Turton E, Waheed W, Woodward J, Mallender E, Deary V

Publication type: Article

Publication status: Published

Journal: The Lancet

Year: 2024

Volume: 403

Issue: 10444

Pages: 2619-2629

Print publication date: 15/06/2024

Online publication date: 15/06/2024

Acceptance date: 04/04/2024

Date deposited: 22/05/2024

ISSN (print): 0140-6736

ISSN (electronic): 1474-547X

Publisher: The Lancet Publishing Group

URL: https://doi.org/10.1016/S0140-6736(24)00700-1

DOI: 10.1016/S0140-6736(24)00700-1


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
NIHR project: 15/136/07
NIHR

Share